96 related articles for article (PubMed ID: 1834193)
1. Progress in chemoprevention of gastrointestinal cancers.
Tempero MA
Curr Opin Oncol; 1991 Aug; 3(4):719-26. PubMed ID: 1834193
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
Reddy BS; Rao CV
J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
[TBL] [Abstract][Full Text] [Related]
3. Biological relevance of adduct detection to the chemoprevention of cancer.
Sharma RA; Farmer PB
Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
[TBL] [Abstract][Full Text] [Related]
4. Potential for chemoprevention.
DeCosse JJ
Cancer; 1982 Dec; 50(11 Suppl):2550-3. PubMed ID: 7139549
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs.
Shaheen NJ; Straus WL; Sandler RS
Cancer; 2002 Feb; 94(4):950-63. PubMed ID: 11920463
[TBL] [Abstract][Full Text] [Related]
6. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
[TBL] [Abstract][Full Text] [Related]
8. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
10. [Chemoprevention of lung cancer. A review about previous studies, results and future developments].
Heckmayr M
Pneumologie; 2004 Jun; 58(6):408-15. PubMed ID: 15216434
[TBL] [Abstract][Full Text] [Related]
11. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
12. Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
Telang NT; Li G; Katdare M
Int J Oncol; 2006 Jun; 28(6):1523-9. PubMed ID: 16685453
[TBL] [Abstract][Full Text] [Related]
13. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
14. Micronutrients as chemopreventive agents.
Reddy BS
IARC Sci Publ; 1996; (139):221-35. PubMed ID: 8923033
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
16. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.
Greenwald P; Kelloff GJ; Boone CW; McDonald SS
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):691-702. PubMed ID: 8672984
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colorectal cancer.
Gwyn K; Sinicrope FA
Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based approach to cancer prevention clinical trials.
Greenwald P; McDonald SS; Anderson DE
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
